95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Analyze analyst forecasts for the company and compare them with competitors.
1.65B
The estimated revenue has increased from the previous period.
1.15B
The estimated EBITDA has increased from the previous period.
1.90
The estimated EPS has increased from the previous period.
807.02M
The estimated net income has increased from the previous period.
758.24M
The estimated EBIT has increased from the previous period.
89.28M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
1.07B
Revenue has increased from the previous period.
5.23%
Revenue growth rate has increased from the previous period.
743.56M
EBITDA has decreased from the previous period.
69.55%
EBITDA margin has decreased from the previous period.
491.61M
EBIT has decreased from the previous period.
45.98%
EBIT margin has decreased from the previous period.
251.95M
Depreciation has increased from the previous period.
358.41M
Total cash has decreased from the previous period.
33.52%
Cash percentage has decreased from the previous period.
9.59M
Receivables have decreased from the previous period.
0.90%
Receivables percentage has decreased from the previous period.
14.72M
Inventories have increased from the previous period.
1.38%
Inventory percentage has increased from the previous period.
13.30M
Accounts payable has decreased from the previous period.
1.24%
Payables percentage has decreased from the previous period.
-241.34M
Capital expenditure has decreased from the previous period.
-22.57%
CapEx percentage has decreased from the previous period.
7.76%
WACC is unchanged from the previous period.
7.74%
Cost of equity is unchanged from the previous period.
88.46%
Cost of debt is unchanged from the previous period.
0.71
Beta is unchanged from the previous period.
453.46M
Diluted shares outstanding is unchanged from the previous period.
6.23M
Total debt is unchanged from the previous period.
25.95B
Total equity is unchanged from the previous period.
25.95B
Total capital is unchanged from the previous period.
0.02%
Debt weighting is unchanged from the previous period.
99.98%
Equity weighting is unchanged from the previous period.
491.28M
EBIAT has decreased from the previous period.
494.81M
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
10.89B
Terminal value is unchanged from the previous period.
9.71B
Enterprise value has decreased from the previous period.
-540.30M
Net debt is unchanged from the previous period.
10.25B
Equity value has decreased from the previous period.
22.61
Equity value per share is unchanged from the previous period.
View analysts' price targets and recommendations, and compare them with competitors.
$100.50
Analysts expect the stock price to increase by 3.93%.
Buy
Positive consensus among analysts.
